Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The VETERANS AFFAIRS, DEPARTMENT OF has issued a Tender notice for the procurement of a new five year et purchase agreement salt lake city heart and kidney transplant rejection test services and reporting in the USA. This Tender notice was published on 22 Jan 2026 and is scheduled to close on 30 Jan 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 134132942, while the tender notice number is 36C25926Q0162 and Registering on the platform.
Procurement Summary
Country: USA
Summary: new five year et purchase agreement salt lake city heart and kidney transplant rejection test services and reporting
Deadline: 30 Jan 2026
Posting Date: 22 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 134132942
Document Ref. No.: 36C25926Q0162
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
RFQ Amendment 36C25926Q0162 0001
Responses to Solicitation Questions and Time Extension
RFQ 36C25926Q0162 is hereby extended until 01/30/2026 at 15:00pm MT.
Quotes are to be provided to [email protected] no later than 15:00pm MT, January 30, 2026.
Responses to questions received are as follows:
Anticipated Volume & Utilization
Does the Government have historical annual test volume data for heart and kidney transplant biopsies?
Answer: Yes.
Does the listed quantity of 20 EA represent an annual estimate, a per-order estimate, or a placeholder for BPA establishment?
Answer: 20 Annual of each, estimated total over the life of the BPA is 100 of each test.
Is there an estimate of the number of Veterans or transplant centers expected to order under the BPA?
Answer: One Facility-Salt Lake City.
Clinical & Technical Scope
4. Is use of the Molecular Microscope Diagnostic System (MMDx) specifically required, or will clinically equivalent molecular rejection assays be considered?
Answer: MMDx is required.
Are FDA-cleared assays required or are CLIA-validated laboratory-developed tests acceptable?
Answer: CLIA-validated laboratory-developed tests are acceptable.
Are there minimum analytical or clinical validation requirements offerors must meet?
Answer: No.
7. What specimen types and minimum tissue requirements are expected?
Answer: Heart tissue bx: two bites 0.5mm or one slightly larger bite. Kidney tissue bx: 5 mm of biopsy.
8. What are the rejection criteria for suboptimal or insufficient specimens?
Answer: Subject to rejection if: Tissue rinsed with saline or placed in formalin; & Tissue should not be: cleaned up of blood/clots, left out in open air long (ideally
Notice ID: 36c25926q0162
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: network contract office 19 (36c259)
Product Service Code: q515 - medical- pathology
NAICS Code: 621511 - Medical Laboratories
Inactive Dates: mar 01, 2026
Inactive Policy: manual
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google